Financials

  • Market Capitalization N/A
  • Employee 3 088
  • Founded 1999
  • CEO Jan G. J. van de Winkel
  • Website www.genmab.com
  • Headquarter Denmark
  • FIGI BBG004MPKM64
  • Industry Biotechnology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5155
BDRX
Biodexa Pharmaceuticals plc - American Depositary Shares
0.87 USD-3.33%-31.50%-40.41%-37.86%78.58 K USD
5164
CMND
Clearmind Medicine Inc. - Common Shares
1.77 USD-2.21%+0.57%+22.07%+73.53%27.98 K USD
5227
OCS
Oculis Holding AG - Ordinary shares
12.21 USD-1.77%-6.72%+10.40%-25.41%0 USD
5240
ANL
Adlai Nortye Ltd - American Depositary Shares
13.78 USD-3.77%+0.58%+8.59%+720.24%0 USD

Frequently asked questions about Genmab A/S ADS

What is the Genmab A/S ADS stock price today?

The current price of Genmab A/S ADS (GMAB) is 33.22. Over the past 24 hours, the stock has changed by -2.58%. Follow the GMAB chart for real-time price dynamics.

What is the stock ticker of Genmab A/S ADS?

Genmab A/S ADS trades under the ticker GMAB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Genmab A/S ADS stock going up?

GMAB has changed by -0.69% over the last week, +15.07% over the last month, and +33.57% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Genmab A/S ADS?

Genmab A/S ADS currently has a market capitalization of 0. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

How many employees does Genmab A/S ADS have?

As of the latest available data, Genmab A/S ADS has 3 088 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Genmab A/S ADS stock?

You can buy Genmab A/S ADS (GMAB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Genmab A/S ADS stock?

Investing in Genmab A/S ADS requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GMAB chart and related analysis on metatrader.com as part of your research.

Genmab A/S - American Depositary Shares

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US.

News